NCT05665738View on ClinicalTrials.gov

Two-fraction HDR Monotherapy for Localized Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2029

Conditions
Prostate AdenocarcinomaLocalized Prostate Carcinoma
Interventions
RADIATION

High Dose Rate Monotherapy

High dose rate brachytherapy delivered in 13.5 Gy x 2 fractions over a single implant procedure 3 hours apart

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER